In order to evaluate anti-tumor efficiency in long-term treatment, anti-BCMA-CAR2 or anti-BCMA-CAR3 T cells were co-cultured with NCI-H929 (BCMAhigh) cells at E:T ratio of 1:2. Here, TNFRSF17 is linked to neoplasm.